14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know
14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know
14位分析師評估福泰製藥：你需要知道的
Vertex Pharmaceuticals (NASDAQ:VRTX) has been analyzed by 14 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
福泰製藥（納斯達克：VRTX）在過去三個月內接受了14位分析師的分析，展現出多種看法，從看好到看淡。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $474.86, a high estimate of $555.00, and a low estimate of $376.00. This current average has increased by 6.67% from the previous average price target of $445.15.
分析師評估的12個月價格目標揭示了更多的見解，其中平均目標爲474.86美元，最高估值爲555.00美元，最低估值爲376.00美元。當前平均值比先前的平均價格目標445.15美元增長了6.67%。
Investigating Analyst Ratings: An Elaborate Study...
分析師評級的...
登入免費觀看全文
登入/註冊